AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34935407 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 27494
Study 34935407 — intervention group
Group type: COMPARATOR
Intervention: Intensive blood pressure lowering
Number of subjects: 27494
Study 34935407 — intervention group
Group type: COMPARATOR
Intervention: Dabigatran vs Warfarin
Number of subjects: 27494
Study 34460844 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian model with shrinkage effect
Number of subjects: 20
Study 34460844 — intervention group
Group type: COMPARATOR
Intervention: Bayesian model with non-shrinkage prior
Number of subjects: 20
Study 34460844 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian method with maximum entropy prior
Number of subjects: 20
Study 34460844 — intervention group
Group type: COMPARATOR
Intervention: Model assuming non-informative priors for multiplicative parameters
Number of subjects: 20
Study 34953525 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (abiraterone acetate 1000 mg daily + prednisolone 5 mg daily)
Number of subjects: 1974
Study 34953525 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (abiraterone acetate + prednisolone + enzalutamide 160 mg daily)
Number of subjects: 1974
Study 34953525 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (abiraterone acetate + prednisolone)
Number of subjects: 1974
Study 34953525 — intervention group
Group type: COMPARATOR
Intervention: ADT alone (control group)
Number of subjects: 1974
Study 34478577 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose anfibatide (2 IU/60 kg)
Number of subjects: 90
Study 34478577 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose anfibatide (3 IU/60 kg)
Number of subjects: 90
Study 34478577 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose anfibatide (5 IU/60 kg)
Number of subjects: 90
Study 34478577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 34478577 — intervention group
Group type: EXPERIMENTAL
Intervention: All anfibatide groups
Number of subjects: 90
Study 34478577 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 33315342 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow tempo (5/0/3/0) barbell squat
Number of subjects: 10
Study 33315342 — intervention group
Group type: COMPARATOR
Intervention: Medium tempo (2/0/2/0) barbell squat
Number of subjects: 10
Study 33315342 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercise protocols (SLO and MED)
Number of subjects: 10
Study 36357595 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach intervention
Number of subjects: 0
Study 36357595 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33407774 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (40 mg)
Number of subjects: 132
Study 33407774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 33913784 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Little Kids parenting programme
Number of subjects: 27
Study 34176383 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional real-world evidence (RWE) at product launch
Number of subjects: 0
Study 34176383 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trial evidence (RCTE)
Number of subjects: 0
Study 33228623 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare financing characteristics
Number of subjects: 51
Study 33228623 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician compensation tied to relative value units
Number of subjects: 51
Study 33228623 — intervention group
Group type: EXPERIMENTAL
Intervention: Grant-based services
Number of subjects: 51
Study 35469070 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse navigator‐led follow‐up system and web portal-smartphone application on top of usual care
Number of subjects: 559
Study 33652129 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded acetaminophen
Number of subjects: 300
Study 33652129 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded ibuprofen
Number of subjects: 300
Study 33652129 — intervention group
Group type: COMPARATOR
Intervention: Control (OTC medications)
Number of subjects: 300
Study 33652129 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence
Number of subjects: 300
Study 34877813 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg
Number of subjects: 607
Study 34877813 — intervention group
Group type: COMPARATOR
Intervention: Edoxaban 75 mg
Number of subjects: 607
Study 32132590 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive weight centile lines based on mixed modelling methods
Number of subjects: 1510
Study 32132590 — intervention group
Group type: EXPERIMENTAL
Intervention: New predictive weight centile lines
Number of subjects: 1510
Study 32132590 — intervention group
Group type: COMPARATOR
Intervention: UK1990 centile lines
Number of subjects: 1510
Study 36602066 — intervention group
Group type: EXPERIMENTAL
Intervention: NMCur-aPDT
Number of subjects: 48
Study 36602066 — intervention group
Group type: COMPARATOR
Intervention: LED
Number of subjects: 48
Study 36602066 — intervention group
Group type: EXPERIMENTAL
Intervention: VITIS®
Number of subjects: 48
Study 36602066 — intervention group
Group type: EXPERIMENTAL
Intervention: NMCur
Number of subjects: 48
Study 37794320 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week individualized motor-cognitive eHealth training with cognitive behavioral elements
Number of subjects: 120
Study 37794320 — intervention group
Group type: COMPARATOR
Intervention: Active control group (individualized 10-week paper-based home exercise program)
Number of subjects: 120
Study 32962685 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education (NE) program on pulse-cereal complementary food for mothers delivered by Health Extension Workers (HEWs) for 9 months
Number of subjects: 772
Study 32962685 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education (NE) program on pulse-cereal complementary food for mothers
Number of subjects: 772
Study 32962685 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving routine health education for 9 months
Number of subjects: 772
Study 32991345 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min ball-tapping exercise
Number of subjects: 21
Study 32991345 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min jogging exercise
Number of subjects: 21
Study 32991345 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 21
Study 32249091 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated securement dressing (ISD) + sterile foam (SF)
Number of subjects: 330
Study 32249091 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive (TA) + non-sterile foam (NSF)
Number of subjects: 330
Study 32249091 — intervention group
Group type: COMPARATOR
Intervention: Bordered polyurethane dressing (BPU) + non-sterile foam (NSF)
Number of subjects: 330
Study 32249091 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 330
Study 32249091 — intervention group
Group type: EXPERIMENTAL
Intervention: No infection at baseline
Number of subjects: 330
Study 32249091 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion by vascular access specialist
Number of subjects: 330
Study 36942119 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterograde technique
Number of subjects: 220
Study 32585079 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteamine 5% cream
Number of subjects: 50
Study 32585079 — intervention group
Group type: COMPARATOR
Intervention: Modified Kligman's formula (MKF)
Number of subjects: 50
Study 32207274 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir administered according to the 3-0-3 titration algorithm (G3)
Number of subjects: 46
Study 32207274 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir administered according to the 2-4-6-8 titration algorithm (G2)
Number of subjects: 46
Study 33301990 — intervention group
Group type: EXPERIMENTAL
Intervention: MOCHA Standard intervention (10-week program including small group discussions, health topic classes, and 60-min aerobic exercise twice a week)
Number of subjects: 0
Study 33301990 — intervention group
Group type: EXPERIMENTAL
Intervention: MOCHA+ Stories Matter program (enhanced intervention using narrative communication strategies)
Number of subjects: 0
Study 32147440 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive local treatment (surgery) for oligometastatic disease in gastric cancer
Number of subjects: 0
Study 32147440 — intervention group
Group type: EXPERIMENTAL
Intervention: Current ongoing randomized clinical studies
Number of subjects: 0
Study 36090495 — intervention group
Group type: COMPARATOR
Intervention: S‐HD
Number of subjects: 40
Study 36090495 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐HD
Number of subjects: 40
Study 36090495 — intervention group
Group type: EXPERIMENTAL
Intervention: HV‐HDF
Number of subjects: 40
Study 33343579 — intervention group
Group type: COMPARATOR
Intervention: HLA-A*02:05, B*58:01, C*07:01, DRB1*03:01 haplotype
Number of subjects: 182
Study 33343579 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-C*04:01 allele and HLA-A*30:02, B*14:02, C*08:02 haplotype
Number of subjects: 182
Study 33343579 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-DRB1*08:01 allele
Number of subjects: 182
Study 33343579 — intervention group
Group type: EXPERIMENTAL
Intervention: G6PDH deficiency
Number of subjects: 182
Study 33343579 — intervention group
Group type: COMPARATOR
Intervention: Influenza vaccination status
Number of subjects: 182
Study 33524131 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-Free Diet (GFD)
Number of subjects: 51
Study 33524131 — intervention group
Group type: COMPARATOR
Intervention: Gluten-Containing Diet (GCD)
Number of subjects: 51
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in visual acuity (VA)
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant placement in at least 1 eye
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Quieting of all eyes active at the beginning of the interval
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Reductions in visual acuity (VA)
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Infections requiring a prescription
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Incident uveitis activity in at least 1 eye
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreous hemorrhage in at least 1 eye
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Declines in visual acuity (VA)
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation in IOP medication
Number of subjects: 0
Study 32717341 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 0
Study 33557924 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative enhancement and cognitive therapy (NECT)
Number of subjects: 120
Study 33557924 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 120
Study 33557924 — intervention group
Group type: EXPERIMENTAL
Intervention: NECT
Number of subjects: 120
Study 32126028 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification without ophthalmic viscosurgical devices (OVDs), using continuous irrigation mode and chopping technique.
Number of subjects: 0
Study 35397367 — intervention group
Group type: EXPERIMENTAL
Intervention: soy milk + PS (1.6 g/day)
Number of subjects: 38
Study 35397367 — intervention group
Group type: COMPARATOR
Intervention: soy milk (Control phase)
Number of subjects: 38
Study 33113535 — intervention group
Group type: EXPERIMENTAL
Intervention: LI-guided therapy
Number of subjects: 290
Study 33113535 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 290
Study 32978540 — intervention group
Group type: EXPERIMENTAL
Intervention: Written information (a take‐home leaflet) on orthodontic pain characteristics and management
Number of subjects: 60
Study 32978540 — intervention group
Group type: COMPARATOR
Intervention: General verbal instructions on orthodontic treatment
Number of subjects: 60
Study 35467599 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook plus Health Professionals (FB+HP)
Number of subjects: 300
Study 35467599 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook (FB)
Number of subjects: 300
Study 35467599 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 300
Study 33838870 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (20–40 mU/m2 per minute) and lipid (Intralipid) infusion
Number of subjects: 15
Study 33838870 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 15
Study 34170931 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural support group session
Number of subjects: 9056
Study 34170931 — intervention group
Group type: COMPARATOR
Intervention: Control (no behavioural support group session)
Number of subjects: 9056
Study 32826008 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined procedure (passive cervical mobilization, active cervical rotation range of motion exercises, and stretching procedures)
Number of subjects: 38
Study 32826008 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure (passive cervical mobilization and active cervical rotation range of motion exercise)
Number of subjects: 38
Study 34333391 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk and rapeseed protein (35 g per day, ratio 54:46 or 30:70)
Number of subjects: 129
Study 34333391 — intervention group
Group type: COMPARATOR
Intervention: Milk protein alone (35 g per day)
Number of subjects: 129
Study 32067218 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin therapy for 6 months
Number of subjects: 90
Study 32067218 — intervention group
Group type: COMPARATOR
Intervention: Control group (women with PCOS without metformin)
Number of subjects: 90
Study 32067218 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin therapy
Number of subjects: 90
Study 35608580 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg orally twice a day (n = 1824)
Number of subjects: 3649
Study 35608580 — intervention group
Group type: COMPARATOR
Intervention: Placebo orally twice a day (n = 1825)
Number of subjects: 3649
Study 33844368 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient bathing product (AFLOAT VET)
Number of subjects: 16
Study 33844368 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% miconazole/2% chlorhexidine shampoo (2% MIC/CHX)
Number of subjects: 16
Study 33844368 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy dogs)
Number of subjects: 16
Study 32130058 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinetrol‐XPur (450 mg per tablet, 2 tablets once a day)
Number of subjects: 100
Study 32130058 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 tablets once a day)
Number of subjects: 100
Study 36014789 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg sodium butyrate twice a day (group A)
Number of subjects: 72
Study 36014789 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 72
Study 32409838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin added to anesthetics (Group G)
Number of subjects: 0
Study 32409838 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug group (Group C)
Number of subjects: 0
Study 34327667 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional and visual identification of EBSLN
Number of subjects: 278
Study 34327667 — intervention group
Group type: COMPARATOR
Intervention: No identification of EBSLN
Number of subjects: 278
Study 34341520 — intervention group
Group type: EXPERIMENTAL
Intervention: Vosoritide (15.0 μg/kg/day)
Number of subjects: 0
Study 34341520 — intervention group
Group type: COMPARATOR
Intervention: Vosoritide (15.0 μg/kg/day) after crossover from placebo
Number of subjects: 0
Study 36147434 — intervention group
Group type: EXPERIMENTAL
Intervention: CDC recommended guidelines for peripheral intravascular catheter insertion (Group 1)
Number of subjects: 200
Study 36147434 — intervention group
Group type: COMPARATOR
Intervention: Standard defined steps during insertion (Group 2)
Number of subjects: 200
Study 36147434 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion at wrist joint
Number of subjects: 200
Study 36147434 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertions during 0–24 h
Number of subjects: 200
Study 36147434 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertions during 25–48 h
Number of subjects: 200
Study 36147434 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertions at 72 h
Number of subjects: 200
Study 35495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastrojejunostomy
Number of subjects: 84
Study 35495374 — intervention group
Group type: COMPARATOR
Intervention: Billroth II with Braun anastomosis
Number of subjects: 84
Study 35495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 84
Study 33923532 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture containing Bifidobacterium animalis subsp. Lactis BB12 and Enterococcus faecium L3, administered daily for 3 months before allergen exposure
Number of subjects: 250
Study 33923532 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture
Number of subjects: 250
Study 33923532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 36617189 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic shoulder pain group
Number of subjects: 39
Study 36617189 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 39
Study 32507490 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministered lidocaine
Number of subjects: 51
Study 32507490 — intervention group
Group type: COMPARATOR
Intervention: Intranasal lidocaine administration
Number of subjects: 51
Study 35134951 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotarix
Number of subjects: 253
Study 35134951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study 33989286 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (twice a week from the 21st day of life till discharge)
Number of subjects: 65
Study 33989286 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 65
Study 32452336 — intervention group
Group type: EXPERIMENTAL
Intervention: Group PM+ (five sessions of 2.5-3 hours each)
Number of subjects: 121
Study 32452336 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC) - brief psycho-education and referral options to primary care services
Number of subjects: 121
Study 35240260 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 24 weeks, 3 times per week
Number of subjects: 25
Study 35240260 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study 33291535 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO_M (CHO–electrolyte solution + MBI)
Number of subjects: 14
Study 33291535 — intervention group
Group type: COMPARATOR
Intervention: Control (non‐carbohydrate solution + travelling introduction audio)
Number of subjects: 14
Study 33291535 — intervention group
Group type: COMPARATOR
Intervention: CHO (CHO–electrolyte solution + travelling introduction audio)
Number of subjects: 14
Study 33823373 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression force <82.5 N for CC
Number of subjects: 25286
Study 33823373 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression force <92.0 N for MLO
Number of subjects: 25286
Study 33823373 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure <7.2 kPa for MLO
Number of subjects: 25286
Study 33823373 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exposures of force and pressure
Number of subjects: 25286
Study 35242209 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 148
Study 35242209 — intervention group
Group type: COMPARATOR
Intervention: Clopidothiol
Number of subjects: 148
Study 33626250 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA vaccine (first dose, days 14-20)
Number of subjects: 596618
Study 33626250 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA vaccine (second dose, 7 or more days after)
Number of subjects: 596618
Study 32819929 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of tranexamic acid (TXA) 1g, intravenous injection 3 hours postsurgery
Number of subjects: 0
Study 32819929 — intervention group
Group type: COMPARATOR
Intervention: Three doses of tranexamic acid (TXA) 1g, intravenous injection at 3, 6, and 12 hours postsurgery
Number of subjects: 0
Study 32819929 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study 35123456 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐m Walk Test
Number of subjects: 38
Study 35123456 — intervention group
Group type: EXPERIMENTAL
Intervention: Figure‐of‐8 Walk Test
Number of subjects: 38
Study 35123456 — intervention group
Group type: EXPERIMENTAL
Intervention: 360‐degree Turn Test
Number of subjects: 38
Study 35123456 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Four Square Step Test
Number of subjects: 38
Study 33972648 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbicide aminopyralid + fluroxypir associated with lecithin
Number of subjects: 6
Study 33972648 — intervention group
Group type: COMPARATOR
Intervention: Herbicide without adjuvants
Number of subjects: 6
Study 32229447 — intervention group
Group type: EXPERIMENTAL
Intervention: Development Group (DG, n=332)
Number of subjects: 498
Study 32229447 — intervention group
Group type: COMPARATOR
Intervention: Validation Group (VG, n=166)
Number of subjects: 498
Study 35223109 — intervention group
Group type: EXPERIMENTAL
Intervention: Grooved lithotripsy stent
Number of subjects: 96
Study 35223109 — intervention group
Group type: COMPARATOR
Intervention: Smooth ureteric stent
Number of subjects: 96